August News Roundup

Each month, we round up diabetes-related news and insights from trusted sources to provide you with ideas, tips, education and more to help you live your best life.   

Here’s the latest! 

Stopping GLP-1s? How Weight Regain Impacts Type 2 Diabetes

Everyday Health 
GLP-1 receptor agonists like semaglutide (Ozempic) and tirzepatide (Mounjaro) have helped reshape type 2 diabetes treatment. While these drugs are intended to be a long-term treatment, research shows that nearly half of people with type 2 diabetes stop taking the medication within one year [Read more]

GLP-1s and Kidney Disease: Potential Benefits and What Experts Say

Forbes 
The kidneys are crucial body parts that filter our blood and help us remove waste. How well they function is often connected to other aspects of health, including metabolic health conditions such as type 2 diabetes and obesity. [Read more] 

New Treatment Using Patients’ Own Tissue Offers Hope for Hard-to-Heal Wounds

Local 12 News Cincinnati  
For patients living with chronic wounds that can be difficult to heal, a treatment that uses a person’s own blood components is offering new hope — particularly for people with diabetes who develop ulcers on their feet or legs [Read more] 

4 Quiet Symptoms of Insulin Resistance a Doctor Monitors in Himself

TODAY 
“I think a lot of people get this mixed up: insulin resistance versus prediabetes versus Type 2 diabetes. There is, of course, a lot of overlap, but insulin resistance can happen without being pre-diabetic, without having diabetes.” [Read more]

What to Eat (and Limit) if You’re Taking a GLP-1 and Have Type 2 Diabetes

Everyday Health  
Once you start taking a GLP-1 for type 2 diabetes, you’ll start eating less. That can be a good thing for your blood sugar level, but it can also introduce an additional challenge. [Read more]